BioXcel Therapeutics (BTAI) announced that it will effect a 1-for-16 reverse stock split of its common stock. The reverse stock split will become effective at 5:00 p.m. Eastern Time on February 7, 2025, with the company’s common stock expected to begin trading on a split-adjusted basis at the opening of the market on Monday, February 10, 2025.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BTAI:
- BioXcel Therapeutics provides clinical, business update
- BioXcel Therapeutics price target lowered to $3 from $5 at H.C. Wainwright
- Biotech Alert: Searches spiking for these stocks today
- Bioxcel Therapeutics Appoints Dr. Rajiv Patni to Board
- BioXcel Therapeutics files to sell 5.1M shares of common stock for holders
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue